Tenax Therapeutics Inc. (TENX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tenax Therapeutics Inc.

    NASDAQ: TENX · Real-Time Price · USD
    7.50
    -0.11 (-1.45%)
    At close: Oct 03, 2025, 3:59 PM
    7.50
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Tenax Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 94.85M 9.79M 2.12M 5.58M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a 1.12K 9.55K 8.44K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 64K 251.58K 345.86K n/a
    Total Current Assets
    		 96.69M 11.68M 3.21M 5.69M
    Property-Plant & Equipment
    		 n/a n/a 186.69K 294.8K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a 1.12K 196.24K 303.24K
    Total Assets
    		 96.69M 11.68M 3.4M 5.99M
    Account Payables
    		 3.16M 2.07M 448.43K 859.64K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 500.9K 624.3K 107.19K
    Other Current Liabilities
    		 n/a 236.88K 245.39K -107.19K
    Total Current Liabilities
    		 4.69M 3.59M 1.85M 1.56M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a 64.2K 183.59K
    Total Liabilities
    		 4.69M 3.59M 1.91M 1.75M
    Total Debt
    		 n/a 500.9K 807.89K 290.78K
    Book Value
    		 91.99M 8.1M 1.49M 4.24M
    Book Value Per Share
    		 6.02 32.65 81.17 330.07
    Common Stock
    		 n/a 30.00 4.58K 2.52K
    Retained Earnings
    		 -314.86M -297.25M -289.54M -278.49M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 91.99M 8.1M 1.49M 4.24M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist